Heat-treated NHS factor VIII concentrate in the United Kingdom-a preliminary study
- 1 June 1986
- journal article
- case report
- Published by Wiley in Clinical and Laboratory Haematology
- Vol. 8 (2) , 85-92
- https://doi.org/10.1111/j.1365-2257.1986.tb00082.x
Abstract
Three patients who have been given intermediate purity NHS heat-treated factor VIII concentrate have been followed prospectively for 7-10 months. None had previously received more than six donor units of blood products containing factor VIII. There were no clinical side effects from concentrate administration, haemostasis was satisfactory and no patient developed clinical or laboratory evidence of hepatitis or HTLV III/LAV infection. Heat treatment resulted in the loss of slightly more than 20% of factor VIII activity but in vivo recovery of factor VIII and half disappearance times were within the expected range.Keywords
This publication has 16 references indexed in Scilit:
- AIDS and haemophilia: morbidity and morality in a well defined population.BMJ, 1985
- HUMAN T-LYMPHOTROPIC VIRUS TYPE III (HTLV-III) INFECTION IN SERONEGATIVE HAEMOPHILIACS AFTER TRANSFUSION OF FACTOR VIIIThe Lancet, 1985
- NON-A, NON-B HEPATITIS AND HEAT-TREATED FACTOR VIII CONCENTRATESThe Lancet, 1985
- TRANSMISSION OF NON-A, NON-B HEPATITIS BY HEAT-TREATED FACTOR VIII CONCENTRATEThe Lancet, 1985
- High risk of non‐A non‐B hepatitis after a first exposure to volunteer or commercial clotting factor concentrates: effects of prophylactic immune serum globulinBritish Journal of Haematology, 1985
- PROGRESSIVE LIVER DISEASE IN HAEMOPHILIA: AN UNDERSTATED PROBLEM?The Lancet, 1985
- ACQUIRED IMMUNODEFICIENCY SYNDROME AND OTHER POSSIBLE IMMUNOLOGICAL DISORDERS IN EUROPEAN HAEMOPHILIACSThe Lancet, 1984
- Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDSScience, 1984
- FATAL AIDS IN A HAEMOPHILIAC IN THE UKThe Lancet, 1983
- A Factor VIII Concentrate of Intermediate Purity and Higher PotencyTransfusion, 1979